These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15516975)

  • 1. Dissection of transcriptional programmes in response to serum and c-Myc in a human B-cell line.
    Schlosser I; Hölzel M; Hoffmann R; Burtscher H; Kohlhuber F; Schuhmacher M; Chapman R; Weidle UH; Eick D
    Oncogene; 2005 Jan; 24(3):520-4. PubMed ID: 15516975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-Myc creates an activation loop by transcriptionally repressing its own functional inhibitor, hMad4, in young fibroblasts, a loop lost in replicatively senescent fibroblasts.
    Marcotte R; Chen JM; Huard S; Wang E
    J Cell Biochem; 2005 Dec; 96(5):1071-85. PubMed ID: 16167342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of myc amplification and overexpression in cell growth, differentiation and death.
    Koskinen PJ; Alitalo K
    Semin Cancer Biol; 1993 Feb; 4(1):3-12. PubMed ID: 8448376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low molecular weight inhibitors of Myc-Max interaction and function.
    Yin X; Giap C; Lazo JS; Prochownik EV
    Oncogene; 2003 Sep; 22(40):6151-9. PubMed ID: 13679853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mnt takes control as key regulator of the myc/max/mxd network.
    Wahlström T; Henriksson M
    Adv Cancer Res; 2007; 97():61-80. PubMed ID: 17419941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation regulates Myc expression via prolonged activation of the mitogen-activated protein kinase pathway.
    Wang Z; Ge L; Wang M; Carr BI
    J Cell Physiol; 2006 Jul; 208(1):133-40. PubMed ID: 16596619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translocations involving c-myc and c-myc function.
    Boxer LM; Dang CV
    Oncogene; 2001 Sep; 20(40):5595-610. PubMed ID: 11607812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The myc family of oncogenes and their presence and importance in small-cell lung carcinoma and other tumour types.
    Prins J; De Vries EG; Mulder NH
    Anticancer Res; 1993; 13(5A):1373-85. PubMed ID: 8239508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects of epidermal growth factor and fetal calf serum in human endometrial carcinoma RL95-2 cells.
    Sallot M; Lascombe I; Bermont L; Jouvenot M
    Anticancer Res; 1997; 17(5A):3499-504. PubMed ID: 9413194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Myc and eIF4F are components of a feedforward loop that links transcription and translation.
    Lin CJ; Cencic R; Mills JR; Robert F; Pelletier J
    Cancer Res; 2008 Jul; 68(13):5326-34. PubMed ID: 18593934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mnt transcriptional repressor is functionally regulated during cell cycle progression.
    Popov N; Wahlström T; Hurlin PJ; Henriksson M
    Oncogene; 2005 Dec; 24(56):8326-37. PubMed ID: 16103876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The c-Myc target gene network.
    Dang CV; O'Donnell KA; Zeller KI; Nguyen T; Osthus RC; Li F
    Semin Cancer Biol; 2006 Aug; 16(4):253-64. PubMed ID: 16904903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of c-myc in cellular growth control.
    Schmidt EV
    Oncogene; 1999 May; 18(19):2988-96. PubMed ID: 10378694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-MYC impairs immunogenicity of human B cells.
    Schlee M; Schuhmacher M; Hölzel M; Laux G; Bornkamm GW
    Adv Cancer Res; 2007; 97():167-88. PubMed ID: 17419945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nm23-M2/NDP kinase B induces endogenous c-myc and nm23-M1/NDP kinase A overexpression in BAF3 cells. Both NDP kinases protect the cells from oxidative stress-induced death.
    Arnaud-Dabernat S; Masse K; Smani M; Peuchant E; Landry M; Bourbon PM; Le Floch R; Daniel JY; Larou M
    Exp Cell Res; 2004 Dec; 301(2):293-304. PubMed ID: 15530864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myc regulates VEGF production in B cells by stimulating initiation of VEGF mRNA translation.
    Mezquita P; Parghi SS; Brandvold KA; Ruddell A
    Oncogene; 2005 Jan; 24(5):889-901. PubMed ID: 15580293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible kinetic analysis of Myc targets in vivo provides novel insights into Myc-mediated tumorigenesis.
    Lawlor ER; Soucek L; Brown-Swigart L; Shchors K; Bialucha CU; Evan GI
    Cancer Res; 2006 May; 66(9):4591-601. PubMed ID: 16651409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
    Choe C; Chen N; Sawadogo M
    Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of N-Myc rapidly causes acute myeloid leukemia in mice.
    Kawagoe H; Kandilci A; Kranenburg TA; Grosveld GC
    Cancer Res; 2007 Nov; 67(22):10677-85. PubMed ID: 18006809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth factor-dependent regulation of survivin by c-myc in human breast cancer.
    Cosgrave N; Hill AD; Young LS
    J Mol Endocrinol; 2006 Dec; 37(3):377-90. PubMed ID: 17170079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.